An enhanced heterologous virus-like particle for human papillomavirus type 16 tumour immunotherapy.

Cervical cancer is caused by high-risk, cancer-causing human papillomaviruses (HPV) and is the second highest cause of cancer deaths in women globally. The majority of cervical cancers express well-characterized HPV oncogenes, which are potential targets for immunotherapeutic vaccination. Here we de...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Khairunadwa Jemon, Vivienne Young, Michelle Wilson, Sara McKee, Vernon Ward, Margaret Baird, Sarah Young, Merilyn Hibma
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science (PLoS) 2013-01-01
Colecção:PLoS ONE
Acesso em linha:http://europepmc.org/articles/PMC3682997?pdf=render
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados